Timothy Gilligan, MD

Timothy Gilligan, MD

Department Hematology and Oncology
Primary Location Cleveland Clinic Main Campus
Type of Doctor Adults Only
Languages English
Surgeon No
Locations
Cleveland Clinic Main Campus
Primary Location

Cleveland Clinic Main Campus

Appointment:
216.444.6833
Desk:
216.444.0391
Fax:
216.444.9464
Specialties & Treatments

Treatment & Services

  • Clinical Trials
View all 1 Treatment & Services +

Specialty in Diseases & Conditions

  • Adrenal Cancer
  • Adrenocortical Carcinoma
  • Bladder Cancer
  • Cancer
  • Facts About Bladder Cancer
  • Germ Cell Tumors
  • Kidney Cancer
  • Penile Cancer
  • Prostate Cancer
  • Seminoma
  • Testicular Cancer
  • Ureteral Cancer
  • Urethral Cancer
View all 13 Specialties +
Insurance

Insurance

Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans
Biography

About Timothy Gilligan, MD

Timothy Gilligan, MD, is a Medical Oncologist at Cleveland Clinic's main campus in Cleveland, Ohio. He is board-certified in medical oncology and specializes in cancers of the testicles, bladder, prostate and kidneys as well as in problems related to cancer survivorship. Dr. Gilligan is co-Director of the Cleveland Clinic Center for Excellence in Healthcare Communication where he teaches communication skills, trains others to teach communication skills and provides physician coaching. He serves as Program Director of the Cleveland Clinic's Hematology-Oncology Fellowship and medical director of the inpatient solid tumor oncology service. Dr. Gilligan has published numerous original scientific articles in peer-reviewed journals, has written dozens of review articles and book chapters and has given dozens of lectures on genitourinary cancers and biomedical ethics. He has written and edited treatment guidelines and cancer-information summaries for national and international organizations, including the National Cancer Institute, the American Society of Clinical Oncology and UpToDate.
Education & Professional Highlights

Education & Professional Highlights

Appointed
2005

Education & Fellowships

Fellowship - Dana-Farber Cancer Institute Harvard Medical School
Medical Oncology
Boston, MA USA
2001

Residency - Brigham & Women's Hospital
Internal Medicine
Boston, MA
1999

Internship - Brigham & Women's Hospital
Internal Medicine
Boston, MA
1997

Medical School - Stanford University School of Medicine
Stanford, CA USA
1996

Graduate - Columbia University
New York, NY USA
1987

Undergraduate - Swarthmore College
Swarthmore, PA USA
1986

Professional Highlights

  • Member, The National Cancer Institute's Adult Treatment Editorial Board
  • Specialty Editor for Testicular Cancer and Penile Cancer, American Society for Clinical Oncology's People Living With Cancer program
  • Member, American Society of Clinical Oncology Quality of Care Committee
  • Chair, American Society of Clinical Oncology Quality of Care Committee Subcommittee on Measures of Quality
  • Chair, American Society of Clinical Oncology Test Materials Development Committee
  • Editorial Board member, <em>The Oncologist</em>

Certifications

  • Internal Medicine - Medical Oncology

Specialty Interests

Testicular cancer, bladder cancer, prostate cancer, kidney cancer, germ cell tumors, cancer survivorship, health disparities, prostate cancer in black men, health education, seminomas

Memberships

  • American Society of Clinical Oncology
  • American Academy on Communication in Healthcare
Research & Publications

Research & Publications

See publications for Timothy Gilligan, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 1/29/2016, Dr. Gilligan has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Patient Satisfaction Reviews

65 Patient Satisfaction Reviews

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Cleveland Clinic.

Overall Star Ratings
5 out of 5
Explains 5
Listens 5
Courtesy, Respect & Concern 5
Knows Medical History 5
Time Spent with Patient 5
Patient Rating of Doctor 4.9

6 Patient Comments

Reviewed on Dec 16, 2016

Good

Reviewed on Nov 14, 2016

I always feel better after I talk with Dr Gilligan about my chemo and future plans. I'll see him in January and look forward to the visit

Reviewed on Aug 31, 2016

everything went well .

Reviewed on May 27, 2016

Dr. was excellent - Much appreciated.

Reviewed on May 23, 2016

I had questions &amp; Dr Gilligan gave me good advise with my concern.

Reviewed on May 20, 2016

Good

Related Videos